Business Description
Zhongyuan Union Cell & Gene Engineering Corp Ltd
NAICS : 325411
ISIN : CNE000000545
Share Class Description:
SHSE:600645: Class ACompare
Compare
Traded in other countries / regions
600645.China IPO Date
1993-05-04Description
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.81 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.83 | |||||
| Interest Coverage | 272.61 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.23 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7 | |||||
| 3-Year EBITDA Growth Rate | 150.7 | |||||
| 3-Year FCF Growth Rate | 11.9 | |||||
| 3-Year Book Growth Rate | 2.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.35 | |||||
| 9-Day RSI | 38.89 | |||||
| 14-Day RSI | 42.46 | |||||
| 6-1 Month Momentum % | 20.77 | |||||
| 12-1 Month Momentum % | 2.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | |||||
| Quick Ratio | 1.48 | |||||
| Cash Ratio | 0.97 | |||||
| Days Inventory | 194.86 | |||||
| Days Sales Outstanding | 137.93 | |||||
| Days Payable | 84.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.13 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.31 | |||||
| Operating Margin % | 11.48 | |||||
| Net Margin % | 6.74 | |||||
| FCF Margin % | 13.12 | |||||
| ROE % | 2.94 | |||||
| ROA % | 2.01 | |||||
| ROIC % | 3.35 | |||||
| ROC (Joel Greenblatt) % | 19.71 | |||||
| ROCE % | 3.5 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 82.46 | |||||
| PE Ratio without NRI | 56.54 | |||||
| Shiller PE Ratio | 104.16 | |||||
| Price-to-Owner-Earnings | 359.78 | |||||
| PEG Ratio | 4.49 | |||||
| PS Ratio | 5.57 | |||||
| PB Ratio | 2.56 | |||||
| Price-to-Tangible-Book | 3.37 | |||||
| Price-to-Free-Cash-Flow | 42.56 | |||||
| Price-to-Operating-Cash-Flow | 30.71 | |||||
| EV-to-EBIT | 57.34 | |||||
| EV-to-EBITDA | 57.34 | |||||
| EV-to-Revenue | 4.9 | |||||
| EV-to-FCF | 40.47 | |||||
| Price-to-Projected-FCF | 1.97 | |||||
| Price-to-Median-PS-Value | 0.8 | |||||
| Price-to-Graham-Number | 2.91 | |||||
| Price-to-Net-Current-Asset-Value | 11.71 | |||||
| Earnings Yield (Greenblatt) % | 1.74 | |||||
| FCF Yield % | 2.26 | |||||
| Forward Rate of Return (Yacktman) % | -7.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhongyuan Union Cell & Gene Engineering Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,593.264 | ||
| EPS (TTM) (Â¥) | 0.24 | ||
| Beta | 1.39 | ||
| Volatility % | 46.53 | ||
| 14-Day RSI | 42.46 | ||
| 14-Day ATR (Â¥) | 0.829176 | ||
| 20-Day SMA (Â¥) | 21.1585 | ||
| 12-1 Month Momentum % | 2.35 | ||
| 52-Week Range (Â¥) | 12.88 - 24.08 | ||
| Shares Outstanding (Mil) | 467.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhongyuan Union Cell & Gene Engineering Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhongyuan Union Cell & Gene Engineering Corp Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhongyuan Union Cell & Gene Engineering Corp Ltd Frequently Asked Questions
What is Zhongyuan Union Cell & Gene Engineering Corp Ltd(SHSE:600645)'s stock price today?
The current price of SHSE:600645 is ¥19.79. The 52 week high of SHSE:600645 is ¥24.08 and 52 week low is ¥12.88.
When is next earnings date of Zhongyuan Union Cell & Gene Engineering Corp Ltd(SHSE:600645)?
The next earnings date of Zhongyuan Union Cell & Gene Engineering Corp Ltd(SHSE:600645) is .
Does Zhongyuan Union Cell & Gene Engineering Corp Ltd(SHSE:600645) pay dividends? If so, how much?
Zhongyuan Union Cell & Gene Engineering Corp Ltd(SHSE:600645) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers